XML 74 R65.htm IDEA: XBRL DOCUMENT v3.23.3
Marketing, Licensing and Distribution Agreements - Vivus (Details)
9 Months Ended 12 Months Ended
Jan. 18, 2022
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Marketing, Licensing and Distribution Agreements          
Noncash decrease in accrued expenses related to Vivus settlement       $ (6,520,283)  
Noncash decrease in accrued inventory purchases related to Vivus Settlement       (14,203,905)  
Noncash decrease in API purchase commitment     $ 694,314 6,232,489  
Gain on settlement with Vivus       3,389,941  
API purchase commitment asset     694,314   $ 663,984
Accrued inventory purchases     46,288    
License Agreement | Royalty on the first $500 million of net sales          
Marketing, Licensing and Distribution Agreements          
Threshold net sales     500,000,000    
License Agreement | Milestone payment to be paid once $250 million in sales has been reached          
Marketing, Licensing and Distribution Agreements          
Threshold net sales     250,000,000    
Milestone payment     6,000,000    
License Agreement | Milestone payment to be paid after $250 million in sales has been reached          
Marketing, Licensing and Distribution Agreements          
Threshold net sales     250,000,000    
Milestone payment     $ 3,200,000    
License Agreement | Vivus, Inc          
Marketing, Licensing and Distribution Agreements          
One-time fee to purchase and receive the license for the commercialization and exploitation of Stendra   $ 70,000,000      
License Agreement | Vivus, Inc | Royalty during the first, second, and third years following the expiration of the Royalty Period          
Marketing, Licensing and Distribution Agreements          
Royalty percentage     2.00%    
License Agreement | Vivus, Inc | Royalty following the fourth and fifth years following the end of the Royalty Period          
Marketing, Licensing and Distribution Agreements          
Royalty percentage     1.00%    
License Agreement | MTPC          
Marketing, Licensing and Distribution Agreements          
Royalty incurred     $ 170,822 $ 135,816  
Royalty receivable         106,115
License Agreement | MTPC | Royalty on the first $500 million of net sales          
Marketing, Licensing and Distribution Agreements          
Royalty percentage     5.00%    
License Agreement | MTPC | Royalty on net sales after $500 million          
Marketing, Licensing and Distribution Agreements          
Royalty percentage     6.00%    
Settlement Agreement | Vivus, Inc          
Marketing, Licensing and Distribution Agreements          
Inventory amount retained - API $ 7,300,000        
Prepayment amount 900,000        
Payment made for purchase order $ 1,542,904        
Percentage of stendra tablets released 100        
Noncash decrease in accrued expenses related to Vivus settlement $ 6,500,000        
Noncash decrease in accrued inventory purchases related to Vivus Settlement 14,200,000        
Noncash decrease in API purchase commitment 6,200,000        
Gain on settlement with Vivus         3,400,000
Raw materials inventory     $ 1,000,000.0    
Settlement Agreement | Vivus, Inc | Other Current Assets          
Marketing, Licensing and Distribution Agreements          
API purchase commitment asset     700,000   700,000
Settlement Agreement | Vivus, Inc | Other Noncurrent Assets          
Marketing, Licensing and Distribution Agreements          
Accrued inventory purchases, other assets     $ 4,400,000   $ 5,100,000
Settlement Agreement | Vivus, Inc | Promissory Note          
Marketing, Licensing and Distribution Agreements          
Prepayment amount 900,000        
Principal amount of notes payable $ 10,201,758